Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

78.15
Delayed Data
As of Jun 29
 +3.00 / +3.99%
Today’s Change
67.88
Today|||52-Week Range
92.85
-7.25%
Year-to-Date
2 Reasons Behind Johnson & Johnson's 15% Year-to-Date Share-Price Increase
Jun 29 / MotleyFool.com - Paid Partner Content
Sanofi's Likely Sweetener for Medivation Panned
Jun 23 / TheStreet.com - Paid Partner Content
Forget Stem Cell Stocks: Here Are 3 Clinical-Stage Biotechs to Buy Instead
Jun 28 / MotleyFool.com - Paid Partner Content
How Big Is the Diabetes Treatment Market?
Jun 22 / MotleyFool.com - Paid Partner Content
A Biotech Stock Turnaround Requires an Alzheimer's Drug Miracle
Jun 27 / TheStreet.com - Paid Partner Content
This New Class Of Medicine Could Reshape Diabetes Treatment
Jun 20 / MotleyFool.com - Paid Partner Content
Incyte Gains on Jakafi's Breakthrough Status for Acute GVHD
Jun 24 / Zacks.com - Paid Partner Content
Diabetes Deep-Dive: What Investors Need to Know About This Devastating Disease
Jun 18 / MotleyFool.com - Paid Partner Content
Eli Lilly And (LLY) Marked As A Barbarian At The Gate
Jun 24 / TheStreet.com - Paid Partner Content
Price of cancer drugs vastly higher in US, according to study
Jun 06 / FT.com - Paid Partner Content

Today’s Trading

Previous close75.15
Today’s open75.88
Day’s range75.87 - 78.24
Volume7,123,712
Average volume (3 months)4,491,343
Market cap$83.0B
Dividend yield2.61%
Data as of 06/29/2016

Growth & Valuation

Earnings growth (last year)+1.35%
Earnings growth (this year)+4.50%
Earnings growth (next 5 years)+13.40%
Revenue growth (last year)+1.75%
P/E ratio35.9
Price/Sales4.50
Price/Book5.70

Competitors

 Today’s
change
Today’s
% change
AGNAllergan+2.83+1.24%
CELGCelgene+1.53+1.57%
AZNAstraZeneca+0.76+2.61%
ABBVAbbVie+1.82+3.03%
Data as of 8:29am ET, 06/30/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$0.85
Annual revenue (last year)$20.0B
Annual profit (last year)$2.4B
Net profit margin12.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
John C. Lechleiter
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts

Partner Offers

Search for Jobs